ARTICLE | Company News
FDA accepts Celltech NDA
June 18, 2001 7:00 AM UTC
The FDA accepted for review an NDA from Celltech (LSE:CCH; CLL) for a twice-daily extended release formulation of codeine and chlorpheniramine to treat coughs in patients 6 years of age and older. ...